dihexa hgf c-met agonist treatment prevents neomycin-induced hair cell loss in Brn3c:mGFP dihexa hgf c-met Schematic representation

When the water-soluble composition of the invention is converted into an aqueous solution for administration, the concentration of the pharmacologically active peptide salt in said solution should preferably be about 0.0000001 to 10 % (w/v), more preferably about 0.000001 to 5% (w/v) or most preferably about 0.00001 to 1% (w/v)

When applied to the scalp or used systemically, they influence key processes that affect hair health

This symptom of my disease has improved by about 40 % after one injection and my urinary frequency and urgency has improved by about 20 %

Examinaremos sus mecanismos moleculares, los resultados de los estudios clnicos y preclnicos, sus aplicaciones potenciales, as como las consideraciones relativas a la seguridad y la regulacin